U.S. Brand Names:
NeoDecadron®
Synonyms:
Dexamethasone and Neomycin
Generic Available:
No
Use:
Treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, lid, cornea, and anterior segment of the globe
Pregnancy Risk Factor:
C
Lactation:
Excretion in breast milk unknown
Contraindications:
Based on neomycin component: Hypersensitivity to neomycin or any component of the formulation, or other aminoglycosides; intestinal obstruction
Based on dexamethasone component: Hypersensitivity to dexamethasone or any component of the formulation; active untreated infections; ophthalmic use in viral, fungal, or tuberculosis diseases of the eye
Warnings/Precautions:
See individual agents.
Adverse Reactions:
<1%: Burning, local irritation or transient stinging; epithelial punctate keratitis, increased intraocular pressure, mydriasis, ptosis, and possible corneal or scleral malacia can occur
Drug Interactions:
Dexamethasone:
Substrate of CYP3A4 (minor);
Induces CYP2A6 (weak), 2B6 (weak), 2C8/9 (weak), 3A4 (weak)
Also see individual agents.
Stability:
Store in tight, light-resistant container
Pharmacodynamics/Kinetics:
See individual agents.
Dosage:
Ophthalmic: Instill 1-2 drops in eye(s) every 3-4 hours
Patient Education:
See individual agents. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to become pregnant. Consult prescriber if breast-feeding.
Nursing Implications:
May cause sensitivity to light, can minimize by wearing sunglasses
Dental Health: Effects on Dental Treatment:
No significant effects or complications reported
Dental Health: Vasoconstrictor/Local Anesthetic Precautions:
No information available to require special precautions
Mental Health: Effects on Mental Status:
None reported
Mental Health: Effects on Psychiatric Treatment:
None reported
Dosage Forms:
Solution, ophthalmic: Neomycin sulfate 0.35% [3.5 mg/mL] and dexamethasone sodium phosphate 0.1% [1 mg/mL] (5 mL) [contains benzalkonium chloride and sodium bisulfite]